Equillium to Present at 9th Annual SVB Leerink Global Healthcare Conference

LA JOLLA, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders, today announced that Bruce Steel, Equillium’s chief executive officer, will present at 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020.

Click to view original post